HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Global routine vaccination coverage--2012.

Abstract
In 1974, the World Health Organization (WHO) established the Expanded Programme on Immunization to ensure that all children have access to routinely recommended vaccines. Despite improvement in global coverage with the third dose of diphtheria-tetanus-pertussis (DTP) vaccine (DTP3), from 5% in 1974 to 83% in 2011, almost one fifth of the world's children still had not received their third dose of the DTP series during their first year of life. In May 2012, the World Health Assembly endorsed the Global Vaccine Action Plan (GVAP) to guide the Decade of Vaccines' vision to extend benefits of immunization to all persons. GVAP's key indicators include achieving and sustaining 90% national DTP3 coverage and ≥80% DTP3 coverage in every district by 2015. During 2012, as in the 2 preceding years, an estimated 83% of infants worldwide received 3 doses of DTP vaccine; however, coverage varied among the WHO regions. Among 194 WHO member states, 131 (68%) achieved ≥90% DTP3 national coverage, and 59 (30%) achieved ≥80% DTP3 coverage in every district. However, 22.6 million children did not receive 3 DTP doses, a key indicator of immunization program performance. Strengthening national immunization systems, especially in countries with the greatest number of undervaccinated children, should be a global priority to reduce morbidity and mortality from vaccine-preventable diseases.
AuthorsCenters for Disease Control and Prevention (CDC)
JournalMMWR. Morbidity and mortality weekly report (MMWR Morb Mortal Wkly Rep) Vol. 62 Issue 43 Pg. 858-61 (Nov 01 2013) ISSN: 1545-861X [Electronic] United States
PMID24172880 (Publication Type: Journal Article)
Chemical References
  • Diphtheria-Tetanus-Pertussis Vaccine
Topics
  • Child, Preschool
  • Developing Countries
  • Diphtheria-Tetanus-Pertussis Vaccine (administration & dosage)
  • Goals
  • Humans
  • Immunization Programs
  • Infant
  • Vaccination (statistics & numerical data)
  • World Health Organization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: